Website Notice Block

Press Releases

Date Title and Summary View
Toggle Summary MediWound's NexoBrid Highlighted in a Presentation at the International Conference on Minimally Invasive Medicine
Rapid Enzymatic Debridement Featured as Novel, Minimally Invasive Treatment for Severe Burns That Significantly Reduces the Incidence and Extent of Surgery
View HTML
Toggle Summary MediWound Reports Fourth Quarter and Year End 2014 Financial Results View HTML
Toggle Summary MediWound to Host Fourth Quarter and Year End 2014 Financial Results Conference Call on February 12, 2015 at 8:30 a.m. Eastern Time View HTML
Toggle Summary MediWound to Ring the NASDAQ Stock Market Closing Bell on February 5, 2015 in Recognition of Burn Awareness Week View HTML
Toggle Summary MediWound Expands Distribution of NexoBrid to Mexico through Agreement with COVALEO SA View HTML
Toggle Summary MediWound to Present at Oppenheimer 25th Annual Healthcare Conference View HTML
Toggle Summary MediWound to Present at Two Upcoming Investor Conferences View HTML
Toggle Summary MediWound Reports Third Quarter 2014 Financial Results View HTML
Toggle Summary MediWound Initiates Post-Marketing Study with NexoBrid® to Treat Severe Burns in Pediatric Patients View HTML
Toggle Summary MediWound to Host Third Quarter 2014 Financial Results Conference Call on November 5, 2014 at 4:30 p.m. Eastern Time View HTML